Literature DB >> 22553533

CTGFsiRNA ameliorates retinal cells apoptosis in streptozotocin-induced diabetic rats.

Hong-Wei Yang1, Xiao-Long Chen, Zhe-Li Liu, Jie Liu, Li-Min Bu.   

Abstract

AIM: To detect the effect of connective tissue growth factor (CTGF) on the apoptosis in the diabetic retina with small interfering RNAs (siRNA) targeting CTGF.
METHODS: A total of 60 rats were divided into 6 groups including control group, diabetic 4, 8, 12, 16 weeks groups, and interference group. Diabetic rats were induced by intraperitoneal streptozotocin (STZ). Retinas were obtained from control, diabetic rats and diabetic rats of interference group treated by intravitreal injection of CTGFsiRNA to suppress the expression of CTGF mRNA. Retinal cells apoptosis was detected by Tunnel staining and mRNA expression of CTGF was analyzed by RT-PCR.
RESULTS: The levels of CTGF and the apoptosis in the retinas of diabetic rats were significantly higher than those in the controls. Apoptosis occurred at 4 weeks after a diabetic model being set up, became serious with the diabetes developing, while CTGF elevated at 8 weeks. The apoptosis cell counts increased to 25.8cells/mm(2) at 24weeks of diabetes. SiRNA-mediated inhibition of CTGF mRNA resulted in a significant decrease in apoptosis. Significant correlations were found between CTGF and apoptosis in the retina.
CONCLUSION: It was suggested that CTGF might be involved in retinal cells apoptosis which is a characteristic of early diabetic retina. SiRNA targeting CTGF seems to have the advantage of ameliorating retinal cells apoptosis.

Entities:  

Keywords:  CTGF; apoptosis; diabetes; retina

Year:  2010        PMID: 22553533      PMCID: PMC3340772          DOI: 10.3980/j.issn.2222-3959.2010.02.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  33 in total

1.  Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat.

Authors:  Christopher J Layton; Glyn Chidlow; Robert J Casson; John P M Wood; Mark Graham; Neville N Osborne
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-08       Impact factor: 4.799

2.  Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.

Authors:  Takeshi Kita; Yasuaki Hata; Kumiko Kano; Muneki Miura; Shintaro Nakao; Yoshihiro Noda; Hiroaki Shimokawa; Tatsuro Ishibashi
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

3.  Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry.

Authors:  S Ozdek; Y H Lonneville; M Onol; I Yetkin; B B Hasanreisoğlu
Journal:  Eye (Lond)       Date:  2002-11       Impact factor: 3.775

4.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.

Authors:  A J Barber; D A Antonetti; T W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

5.  SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation.

Authors:  X D Zhou; M M Xiong; F K Tan; X J Guo; F C Arnett
Journal:  Arthritis Rheum       Date:  2006-12

6.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy.

Authors:  J Kyle Krady; Anirban Basu; Colleen M Allen; Yuping Xu; Kathryn F LaNoue; Thomas W Gardner; Steven W Levison
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

Review 7.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Authors:  Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza E B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Gregory I Liou; R William Caldwell
Journal:  Curr Drug Targets       Date:  2005-06       Impact factor: 3.465

8.  Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.

Authors:  Xiaodong Zhou; Filemon K Tan; Xinjian Guo; Debra Wallis; Dianna M Milewicz; Sarah Xue; Frank C Arnett
Journal:  Arthritis Rheum       Date:  2005-01

9.  Expression of apoptosis markers in the retinas of human subjects with diabetes.

Authors:  Ahmed M Abu-El-Asrar; Lieve Dralands; Luc Missotten; Ibrahim A Al-Jadaan; Karel Geboes
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

10.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.

Authors:  S-H Park; J-W Park; S-J Park; K-Y Kim; J-W Chung; M-H Chun; S-J Oh
Journal:  Diabetologia       Date:  2003-07-31       Impact factor: 10.122

View more
  3 in total

Review 1.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

2.  Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.

Authors:  Bojie Hu; Yan Zhang; Qing Zeng; Qian Han; Lijuan Zhang; Mian Liu; Xiaorong Li
Journal:  Int J Mol Sci       Date:  2014-01-22       Impact factor: 5.923

3.  CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.

Authors:  Yunzhuo Ren; Chunyang Du; Li Yan; Jingying Wei; Haijiang Wu; Yonghong Shi; Huijun Duan
Journal:  Drug Des Devel Ther       Date:  2015-07-31       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.